NRP1 and colorectal carcinoma: Therefore, the present meta-analysis aimed at determining the potential role of NRP1 as an independent biomarker in the cancer prognosis of CRC and liver cancer patients, as well as its correlation with several tumor-associated clinicopathological features, in order to evaluate NRP1 as a useful target for the pharmacological landscape of these cancers.